Holdings

Vitality Portfolio

As of Mar 31, 2026, Vitality Portfolio reported 31 positions worth US$1.95M. Largest: argenx SE, Eli Lilly and Company and Ascendis Pharma A/S. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
argenx SE235US$172Kfirst reportMar 31, 2026
Eli Lilly and Company181US$166Kfirst reportMar 31, 2026
Ascendis Pharma A/S512US$117Kfirst reportMar 31, 2026
Nektar Therapeutics1,412US$102Kfirst reportMar 31, 2026
Thermo Fisher Scientific Inc186US$91,425first reportMar 31, 2026
Align Technology, Inc.521US$89,315first reportMar 31, 2026
Enliven Therapeutics, Inc.2,126US$83,339first reportMar 31, 2026
10x Genomics, Inc.3,801US$80,695first reportMar 31, 2026
NewAmsterdam Pharma Company N.V.2,383US$76,280first reportMar 31, 2026
CeriBell, Inc.3,915US$71,762first reportMar 31, 2026